Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

3 results about "Araliaceae" patented technology

The Araliaceae is a family made of 52 genera and 700 species of flowering plants including perennial herbs, trees, vines and succulents. The family has large, usually alternate leaves, five-petaled flowers arranged in clusters, and berries. Some genera, such as 'the ivies 'Hedera, are used as ornamental foliage plants, and the family also includes the Panax ginseng, the source of ginseng used in traditional Chinese medicine.

A coffee composition with immune-boosting and anti-tumor effects

This invention relates to the field of pharmaceutical and food technology, specifically to a coffee composition that enhances immunity. This coffee composition can be used to prepare pharmaceuticals or foods that enhance immunity and have anti-tumor effects. The coffee composition comprises an extract from an Araliaceae plant and coffee. The Araliaceae plant is one or more of ginseng, Panax notoginseng, or American ginseng. The Araliaceae plant extract comprises 2-12 parts, and coffee comprises 20-100 parts. The coffee composition may also contain extracts of the following ingredients: Codonopsis pilosula, Astragalus membranaceus, jujube, wolfberry, ginger, and licorice, with the following amounts: Codonopsis pilosula 2-5 parts, Astragalus membranaceus 2-5 parts, jujube 2-10 parts, wolfberry 2-10 parts, ginger 2-10 parts, and licorice 2-10 parts. The coffee composition of this invention exhibits significant immune-enhancing and anti-tumor activities.
Owner:YANBIAN UNIV

A rapid virus-free cloning method and reagent combination for medicinal plant tissue culture

PendingCN122375478ABiotechnologyEleutherococcus gracilistylus
The present application relates to the technical field of medicinal plant tissue culture, in particular to a rapid virus-free cloning method and reagent combination for medicinal plant tissue culture. The method comprises the following steps: pretreatment and disinfection of explants, precise virus elimination, preparation of dynamic adaptive medium, rapid propagation, real-time high-throughput detection of virus-free, seedling raising and transplanting, etc. The reagent combination comprises a multifunctional degradable reagent kit, intelligent response type nano disinfection microcapsules, special reagents such as composite virus elimination liquid, etc. The virus elimination rate is greater than or equal to 95%, the survival rate of explants is greater than or equal to 90%, the propagation cycle is shortened by 30%, the detection time is less than or equal to 2 hours, the survival rate of transplanting is greater than or equal to 85%, and the degradation rate of reagents is greater than or equal to 90%. The present application is suitable for herbaceous, woody and liana medicinal plants of the families of Araliaceae, Eucommiaceae, Orchidaceae and Campanulaceae, etc., can realize stable virus elimination and propagation effect, significantly improve the virus-free cloning efficiency and seedling quality, and meet the green production demand.
Owner:CHANGZHI UNIV

American ginseng root triterpenoid saponin compound and application thereof

PendingCN121319100AOrganic active ingredientsNervous disorderEleutherococcus gracilistylusTriterpenoid saponin
The invention relates to the field of research on chemical effective components of traditional Chinese medicines, and relates to a tetracyclic triterpenoid compound which is separated and identified from an araliaceae ginseng plant Panax quinquefolius L.. According to the present invention, the compounds 1-4 are new compounds, the in vitro cell experiment results show that the compounds provide significant neuroprotection effects for human neuroblastoma cells SH-SY5Y induced by an in vitro Parkinson's disease model MPP +, the preparation method of the compounds is simple, the activity is excellent, and the new material basis is provided for the prevention and treatment of Parkinson's disease (PD).
Owner:HEILONGJIANG UNIV OF CHINESE MEDICINE